USE OF EPIDERMAL GROWTH FACTOR IN THE MANUFACTURE OF A PHARMACEUTICAL INJECTION COMPOSITION FOR PREVENTING DIABETIC LIMB AMPUTATION

摘要

The invention relates to the use of Epidermal Growth Factor (EGF) in a preferably-injectable pharmaceutical composition which is administered by means of infiltration into and around chronic cutaneous ischaemic lesions in order to prevent diabetic foot amputation.